Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pembrolizumab (keytruda) (2 trials)
SMT-NK (1 trial)
allogeneic natural killer cells (1 trial)
Biliary Tract Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (3 total)